坦素通过整合素相关激酶减轻心脏缩:可能的机制
Asma S Alonazi1, Anfal F Bin Dayel1, Hetoun A Alomer1
1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Fundamental & clinical pharmacology
|August 8, 2025
概括
坦素是一种α1A-腺素受体阻断剂,通过调节血管生成途径来减少心脏缩. 这项研究表明tamsulosin.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏缩可以发展为心力衰竭,血管生成起着关键作用.
- 综合素相关激酶 (ILK) 通过血管内皮生长因子 (VEGF) 对心脏血管生成至关重要.
- 阿尔法1A腺受体阻塞对ILK介导血管生成的影响尚不清楚.
研究的目的:
- 为了研究tamsulosin的作用,一个α1A-adrenoceptor对手,在ILK相关的血管生成在心脏缩.
- 探索向α1A-腺受体在预防心脏缩方面的治疗潜力.
主要方法:
- 威斯塔鼠被分配到对照组,因异二醇 (ISO) 诱导的过度缩小,坦苏洛辛治疗或联合坦苏洛辛+ISO组.
- 评估了心脏缩指数,损伤标志物和血管生成/信号蛋白的表达.
主要成果:
- 坦素显著降低了心脏缩和相关生物标志物.
- 坦素治疗逆转了心脏组织损伤.
- 与坦苏洛辛一起观察到VEGF,eNOS,ILK,p-PI3K,p-Akt,Flt-1和PECAM-1表达的调节.
结论:
- 用tamsulosin抑制α1A-adrenoceptors是一种潜在的治疗策略,可以预防心脏缩.
- 这种效应通过涉及ILK,VEGF,eNOS,PI3K和Akt的信号传导通路进行介导.
更多相关视频
08:34Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
Published on: September 25, 2017
24.6K
10:57Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta
Published on: September 12, 2017
8.6K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
509
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
925
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
925
01:17Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
885
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
885
01:17Antihypertensive Drugs: Action of β1 Blockers
612
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
612
01:22Heart Failure Drugs: Diuretics
486
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
486